Table 1.
Strain or plasmid | Genotype or descriptiona | Reference or source |
---|---|---|
Strains | ||
E. coli | ||
XL10 | Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac Hte [F′ proAB lac IqZΔM15 Tn10(Tetr) Amy Cmr] | Stratagene |
BL21-CodonPlus(DE3)-RIL | F− ompT hsdS(rB− mB−) dcm+ Tetr gal λ (DE3) endA Hte [argU ileY leuW Cmr] | Stratagene |
EC1000 | F− RepA+ araD139 (araABC-leu)7679 galU galK lacX74 rspL thi Kmr | 61 |
BL21 Star-pLysS | F− omp T hsdSB(rB− mB−) gal dcm rne 131 (DE3) pLysS (Camr) | Invitrogen |
Top10 | F− mcr A Δ(mrr-hsdRMS-mcrBC) ϕ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara leu)7697 galU galK rpsL (Strr) endA1 nupG | Invitrogen |
DH5α | F− ϕ80lacZΔM15 Δ(lacZ YA-argF)U169 recA1 endA1 hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1 λ− | Invitrogen |
One Shot Mach1-T1R | F− ϕ80(lacZ)ΔM15 Δlac X74 hsdR(rK− mK+) ΔrecA1398 endA1 tonA | Invitrogen |
E. faecalis | ||
JH2-2 | Rifr Fusr | 62 |
OG1RF | Rifr Fusr | 63 |
CK111 | OG1Sp upp4::P23repA4 Specr | 39 |
OG1X | Smr | 64 |
Plasmids | ||
pIP501 | tra+ Cmr MLSr | 65 |
pMAL-c2x | Ptac lacIq malE lacZ Apr | New England Biolabs |
pQTEV | Pt4 lacIq His7 Apr | 38 |
pBlueScript SK− | pUC ori lacZ Apr | Stratagene |
pCJK47 | oriTpCF10 P-pheS* pORI280 derivative Emr | 39 |
pCF10-101 | pCF10ΔoriT2 | 39 |
pKA | pCJK47 aacA-aphD at BglII site; Emr Gentr | This study |
pKAΔtraG | pKA with traG up- and downstream regions at EcoRI/XbaI sites | This study |
pIP501ΔtraG | pIP501 traG in-frame deletion | This study |
pEU327 | E. coli/G+ bacterial shuttle plasmid, Specr xylA promoter | 42 |
pEU327-traGΔTMH | pEU327 with traGΔTMH | This study |
Tetr, tetracycline resistance; Cmr, chloramphenicol resistance; Kmr, kanamycin resistance; Rifr, rifampin resistance; Fusr, fusidic acid resistance; Specr, spectinomycin resistance; Smr, streptomycin resistance; Apr, ampicillin resistance; Gentr, gentamicin resistance; MLSr, macrolide-lincosamide-streptogramin B resistance; tra+, transfer proficient.